| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/15/2007 | US20070061908 Transgenic animal for screening therapeutic agents for brain tumors |
| 03/15/2007 | US20070061907 Inhibitor of differentiation knockout mammals and methods of use thereof |
| 03/15/2007 | US20070061906 Human T2R75 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061905 screening mammalian chemosensory G Protein-Coupled Receptors active in taste signaling; genes and cDNA encoding such receptors |
| 03/15/2007 | US20070061904 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061903 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste |
| 03/15/2007 | US20070061902 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 03/15/2007 | US20070061901 Methods to inhibit growth of prostate cancer cells |
| 03/15/2007 | US20070060743 For diagnostics, forensics, gene mapping; identification of mutations responsible for genetic disorders or other traits, to assess biodiversity, and to produce many other types of data and products dependent on DNA and amino acid sequences |
| 03/15/2007 | US20070060742 for new human tumor necrosis factor receptor designated as Ztnfr12; usefulness in both basic research and as therapeutics |
| 03/15/2007 | US20070060740 Protein crystal |
| 03/15/2007 | US20070060521 Inhibition of STAT3 signal transduction for human cancer therapy |
| 03/15/2007 | US20070060520 Use of anti-prolactin agents to treat proliferative conditions |
| 03/15/2007 | US20070060518 Immunogens; plasmids; directly interact with major histocompatability complex, improving immunology |
| 03/15/2007 | US20070060515 Epithelial cell specific growth factor keratinocyte growth factor (KGF) |
| 03/15/2007 | US20070060514 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/15/2007 | US20070060513 Method for increasing the serum half-life of a biologically active molecule |
| 03/15/2007 | US20070060507 Growth factor homolog zvegf3 |
| 03/15/2007 | US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 03/15/2007 | US20070059825 Cytokine zalpha11 ligand antibodies |
| 03/15/2007 | US20070059810 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 03/15/2007 | US20070059809 Corynebacterium glutamicum genes encoding regulatory proteins |
| 03/15/2007 | US20070059808 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection |
| 03/15/2007 | US20070059806 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 03/15/2007 | US20070059804 polynucleotides that code cysteine mutant proteins that bind to their cognate receptor or exhibit antiviral activity |
| 03/15/2007 | US20070059803 Mammalian cytokines; related reagents and methods |
| 03/15/2007 | US20070059802 Polypeptides and nucleic acids derived from S. pneumoniae that are useful as reagents for diagnosis of bacterial infection, components of effective antibacterial vaccines, and/or as targets for antibacterial drugs; genetic enginnering; nucleotide sequences; binding mRNA to block protein translation |
| 03/15/2007 | US20070059801 Recombinant expression vector comprising nucleic acid linked to transcription regulatory element; prophylaxis and treatment of bacterial infections |
| 03/15/2007 | US20070059800 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 03/15/2007 | US20070059799 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 03/15/2007 | US20070059798 Polypeptides useful for molecular weight determinations |
| 03/15/2007 | US20070059797 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell |
| 03/15/2007 | US20070059796 Binding motif and methods of regulating cell function |
| 03/15/2007 | US20070059795 Engineered zinc finger proteins for regulation of gene expression |
| 03/15/2007 | US20070059793 Nogo receptor binding protein |
| 03/15/2007 | US20070059792 convergent assembly of a plurality of pairs of oligopeptides; stable C-terminal disulfide-protected carboxythioester group that can be deprotected to spontaneously generate a free C-terminal thioester; allows a single precursor to participate in a succession of chemical ligation reactions |
| 03/15/2007 | US20070059783 Method of identifying markers diagnostic of disease and uses therefor in the diagnosis of cancer |
| 03/15/2007 | US20070059776 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| 03/15/2007 | US20070059767 Method of identifying N-terminal proBNP |
| 03/15/2007 | US20070059759 Human T2R63 receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070059758 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| 03/15/2007 | US20070059756 Immunointeractive molecules and their uses in treating subjects suffering from Hev b 5 allergies |
| 03/15/2007 | US20070059744 Corynebacterium glutamicum genes encoding novel proteins |
| 03/15/2007 | US20070059738 Administering to host a therapeutically effective amount of an agent which prevents the interaction of mucosal addressin cell adhesion molecule-1 with a ligand therefor |
| 03/15/2007 | US20070059730 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 03/15/2007 | US20070059729 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer |
| 03/15/2007 | US20070059724 Novel compositions and methods for lymphoma and leukemia |
| 03/15/2007 | US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 03/15/2007 | US20070059721 MAGI polynucleotides, polypeptides, and antibodies |
| 03/15/2007 | US20070059702 Disease related protein network |
| 03/15/2007 | US20070059699 Methods for detecting toxic and non-toxic cyanobacteria |
| 03/15/2007 | US20070059693 nucleic acid molecule characterized by being able to self-anneal into a hairpin conformation, and hybridizes to a target nucleic acid; sensor chip that includes a fluorescence quenching surface and nucleic acid molecules |
| 03/15/2007 | US20070059689 Hybrid glycosylated products and their production and use |
| 03/15/2007 | US20070059688 Gastrointestinal chemosensory receptors |
| 03/15/2007 | US20070059684 Method of identifying an antiviral agent |
| 03/15/2007 | US20070059681 Method for production of bioresorable microparticles, microparticles thus obtained and use thereof |
| 03/15/2007 | US20070059329 Unexpected surface proteins in meningococcus |
| 03/15/2007 | US20070059326 Escherichia coli-derived vaccine and therapy against botulism |
| 03/15/2007 | US20070059325 Genetic vaccine against PWD circovirus |
| 03/15/2007 | US20070059324 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 03/15/2007 | US20070059320 Method for ameliorating pain by modification of NMDA receptors through inhibition of Src |
| 03/15/2007 | US20070059316 Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agents |
| 03/15/2007 | US20070059313 Homogeneous preparations of il-28 and il-29 |
| 03/15/2007 | US20070059303 monoclonal antibody for prevention and treatment of allergies, asthma, crohn's and lymes disease, arthritis, diabetes, glomerularnephritis, vision defects, skin disorders, sarcoidosis and viral diseases |
| 03/15/2007 | US20070059294 Therapeutiv preparation for hematopoietic disease |
| 03/15/2007 | US20070059291 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) |
| 03/15/2007 | US20070059284 Methods of treating infections using il-21 |
| 03/15/2007 | US20070059283 Feline IL-18 nucleic acid molecules |
| 03/15/2007 | US20070059279 Pharmaceutical composition for preventing or treating malignant glioma |
| 03/15/2007 | US20070059245 Protein cages for the delivery of medical imaging and therapeutic agents |
| 03/15/2007 | CA2812794A1 Targeted identification of immunogenic peptides |
| 03/15/2007 | CA2623412A1 Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function |
| 03/15/2007 | CA2622069A1 Treatment of diabetes related obesity |
| 03/15/2007 | CA2621973A1 Chimeric hcn channels |
| 03/15/2007 | CA2621666A1 Antigens for vaccination against and detection of mycoplasma suis |
| 03/15/2007 | CA2621536A1 A transgenic plant having enhanced drought tolerance |
| 03/15/2007 | CA2621439A1 Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| 03/15/2007 | CA2621414A1 Mmp-7 and adf derived tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules |
| 03/15/2007 | CA2621389A1 Tumor-associated peptides binding promiscuously to human leukocyte antigen (hla) class ii molecules |
| 03/15/2007 | CA2621272A1 Anchoring disruption molecules |
| 03/15/2007 | CA2621161A1 Methods for promoting stem cell proliferation and survival |
| 03/15/2007 | CA2620713A1 Immunoglobulin comprising predominantly a man7glcnac2, man8glcnac2 glycoform |
| 03/15/2007 | CA2620633A1 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |
| 03/15/2007 | CA2620132A1 Lactoferrin complex and method of producing the same |
| 03/15/2007 | CA2558125A1 Crystal structure of a complex of integron integrase from vibrio cholerae bound to a recombination substrate |
| 03/14/2007 | EP1762623A1 Methods for producing biologically active peptide dimers |
| 03/14/2007 | EP1762620A2 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 03/14/2007 | EP1762619A2 Multiple-tumor aberrant growth genes |
| 03/14/2007 | EP1762617A1 Method for manufacturing recombinant polyclonal proteins |
| 03/14/2007 | EP1762614A2 Tumor-specific promoters |
| 03/14/2007 | EP1762613A2 Insertion sequence elements derived from ralstonia solanacearum |
| 03/14/2007 | EP1762612A2 Insertion sequence elements derived from ralstonia solanacearum |
| 03/14/2007 | EP1762610A1 Truncated dance, dance complex and method of using these |
| 03/14/2007 | EP1762576A1 Process for separating alpha-1-proteinase inhibitor from Cohn Fraction IV1+IV4 paste |
| 03/14/2007 | EP1762575A1 Identification of tumor-associated antigens for diagnosis and therapy |
| 03/14/2007 | EP1762574A2 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 03/14/2007 | EP1762245A2 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| 03/14/2007 | EP1761784A2 Identification of ergothioneine transporter and therapeutic uses thereof |
| 03/14/2007 | EP1761776A1 Use of the receptor gpr86 |
| 03/14/2007 | EP1761638A2 Methods and agents for screening for compounds capable of modulating vegf expression |